locally advanced or metastatic nsclc or mesothelioma
Item
diagnosis of locally advanced or metastatic (stage iii or iv at entry) non-small cell lung cancer (nsclc) or mesothelioma
boolean
C0007131 (UMLS CUI [1,1])
C0677984 (UMLS CUI [1,2])
C0027627 (UMLS CUI [1,3])
C0025500 (UMLS CUI [2,1])
C0677984 (UMLS CUI [2,2])
C0027627 (UMLS CUI [2,3])
third space fluid
Item
presence of third-space fluid (fluid around the lungs or abdomen).
boolean
C0031039 (UMLS CUI [1])
C0003962 (UMLS CUI [2])
C0032227 (UMLS CUI [3])
ecog
Item
eastern cooperative oncology group performance status of 0 or 1.
boolean
C1520224 (UMLS CUI [1])
cancer therapy
Item
prior anticancer treatment (except radiation) must be completed at least 3 weeks prior to study enrollment, and the patient must have recovered from the sharp toxic effects the anticancer treatment.
boolean
C0920425 (UMLS CUI [1])
life expectancy
Item
estimated life expectancy of at least 8 weeks.
boolean
C0023671 (UMLS CUI [1])
not marketed drug
Item
have received treatment within the last 30 days with a drug that was not a marketed product.
boolean
C0013227 (UMLS CUI [1,1])
C3640176 (UMLS CUI [1,2])
active infection
Item
active infection that, in the opinion of the investigator, would not allow the patient to tolerate therapy.
boolean
C0009450 (UMLS CUI [1])
pregnancy
Item
pregnancy.
boolean
C0032961 (UMLS CUI [1])
breast feeding
Item
breast-feeding.
boolean
C0006147 (UMLS CUI [1])
weight loss
Item
significant weight loss (that is, greater than or equal to 10% of body weight) over the 6 weeks before study entry.
boolean
C1262477 (UMLS CUI [1])
brain metastasis
Item
brain metastases.
boolean
C0220650 (UMLS CUI [1])